Kervansaray Yatirim Holding A.S. (IST:KERVN)

Ligand Pharmaceuticals Revenue

Kervansaray Yatirim Holding A.S. had revenue of 542.25K TRY in the quarter ending March 31, 2025, a decrease of -60.48%. This brings the company's revenue in the last twelve months to 2.37M, up 14.70% year-over-year. In the year 2024, Kervansaray Yatirim Holding A.S. had annual revenue of 3.20M with 173.36% growth.

• Revenue (ttm): 2.37M
• Revenue Growth: +14.70%
• P/S Ratio: 604.52
• Revenue / Employee: 262.85K
• Employees: 9
• Market Cap: 1.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.20M	2.03M	173.36%
Dec 31, 2023	1.17M	1.16M	16,343.71%
Dec 31, 2022	7.11K	-73.98M	-99.99%
Dec 31, 2021	73.99M	20.91M	39.39%
Dec 31, 2020	53.08M	-103.97M	-66.20%